| | |
mean ± SD
|
P-value
|
|---|
|
Overall
| |
6.80 ± 27.96
| |
|
Age Groups
|
≤70 years
|
9.40 ± 34.94
|
0.090
|
| |
> 70 years
|
2.45 ± 5.10
|
|
Total gleason scoreª
|
6
|
0.25 ± 1.60
|
0.001
|
|
7
|
1.55 ± 4.64
|
|
8
|
3.11 ± 5.46
|
|
9
|
24.92 ± 55.06
|
|
WHO grade groupª
|
Grade 1
|
0.25 ± 1.60
|
0.003
|
|
Grade 2
|
1.20 ± 4.15
|
|
Grade 3
|
3.75 ± 7.50
|
|
Grade 4
|
3.11 ± 5.46
|
|
Grade 5
|
24.92 ± 55.06
|
|
Tumor Quantificationª
|
< 10%
|
0.52 ± 2.50
|
0.091
|
|
10–50%
|
1.28 ± 4.26
|
|
> 50%
|
12.00 ± 37.39
|
|
Perineural invasion
|
Present
|
5.28 ± 6.77
|
0.643
|
|
Absent
|
7.71 ± 35.01
|
|
Lymphovascular invasion
|
Present
|
5.00 ± 0.00
|
0.910
|
|
Absent
|
6.85 ± 28.31
|
|
Extraprostatic extension
|
Present
|
0.00 ± 0.00
|
0.510
|
|
Absent
|
7.21 ± 28.74
|
|
Seminal vesicle invasion
|
Present
|
6.00 ± 6.92
|
0.954
|
|
Absent
|
6.83 ± 28.41
|
- Independent t test was applied.
- ªANOVA was applied
- P ≤ 0.05, considered as significant
